| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-10 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |